242 related articles for article (PubMed ID: 19300157)
21. Outcomes of orbital implants after evisceration and enucleation in patients with endophthalmitis.
Hui JI
Curr Opin Ophthalmol; 2010 Sep; 21(5):375-9. PubMed ID: 20489621
[TBL] [Abstract][Full Text] [Related]
22. The use of autogenous sclera as wrapping material in hydroxyapatite implantation.
Yoon JS; Lew H; Kook KH; Lee SY
Ophthalmologica; 2009; 223(1):7-11. PubMed ID: 18849630
[TBL] [Abstract][Full Text] [Related]
23. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
Toh T; Bevin TH; Molteno AC
Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
[TBL] [Abstract][Full Text] [Related]
24. Mersilene mesh versus sclera in wrapping hydroxyapatite orbital implants.
Kassaee A; Kashkouli MB; Panjtanpanah M; Sadeghi A; Tabatabaee Z
Ophthalmic Plast Reconstr Surg; 2006; 22(1):41-4. PubMed ID: 16418664
[TBL] [Abstract][Full Text] [Related]
25. Synthetic hydroxyapatite-based integrated orbital implants: a human pilot trial.
Kundu B; Sinha MK; Mitra S; Basu D
Indian J Ophthalmol; 2005 Dec; 53(4):235-41. PubMed ID: 16333171
[TBL] [Abstract][Full Text] [Related]
26. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology.
Custer PL; Kennedy RH; Woog JJ; Kaltreider SA; Meyer DR
Ophthalmology; 2003 Oct; 110(10):2054-61. PubMed ID: 14522788
[TBL] [Abstract][Full Text] [Related]
27. Long-term Surgical Outcomes of the Multi-purpose Conical Porous Synthetic Orbital Implant.
Kang MJ; Jung SK; Cho WK; Paik JS; Yang SW
Korean J Ophthalmol; 2015 Oct; 29(5):294-300. PubMed ID: 26457034
[TBL] [Abstract][Full Text] [Related]
28. Long-term complications of different porous orbital implants: a 21-year review.
Lin CW; Liao SL
Br J Ophthalmol; 2017 May; 101(5):681-685. PubMed ID: 27474155
[TBL] [Abstract][Full Text] [Related]
29. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
[TBL] [Abstract][Full Text] [Related]
30. A new technique with the hydroxyapatite implant.
Suvağ N; Katircioğlu Y; Duman S
Jpn J Ophthalmol; 2004; 48(2):179-80. PubMed ID: 15060803
[No Abstract] [Full Text] [Related]
31. Primary placement of a titanium sleeve in hydroxyapatite orbital implants.
Liao SL; Chen MS; Lin LL
Eye (Lond); 2005 Apr; 19(4):400-5. PubMed ID: 15297860
[TBL] [Abstract][Full Text] [Related]
32. Porous Versus Nonporous Orbital Implants After Enucleation for Uveal Melanoma: A Randomized Study.
Ho VWM; Hussain RN; Czanner G; Sen J; Heimann H; Damato BE
Ophthalmic Plast Reconstr Surg; 2017; 33(6):452-458. PubMed ID: 27861329
[TBL] [Abstract][Full Text] [Related]
33. Enucleation with reverse replacement of sclera as an alternative to conventional evisceration.
Madill S; Maclean H
Orbit; 2005 Mar; 24(1):23-8. PubMed ID: 15764112
[TBL] [Abstract][Full Text] [Related]
34. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
[TBL] [Abstract][Full Text] [Related]
35. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
Shah SU; Shields CL; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
[TBL] [Abstract][Full Text] [Related]
36. Comparison of orbital prosthesis motility following enucleation or evisceration with sclerotomy with or without a motility coupling post in dogs.
Yi NY; Park SA; Jeong MB; Kim WT; Kim SE; Kim JY; Chae JM; Jang KJ; Seong JK; Seo KM
Vet Ophthalmol; 2009; 12(3):139-51. PubMed ID: 19392873
[TBL] [Abstract][Full Text] [Related]
37. ["On the table evisceration": Technical note].
Guigue Benayoun H; Foletti JM; Guyot L
Rev Stomatol Chir Maxillofac Chir Orale; 2016 Feb; 117(1):36-41. PubMed ID: 26776742
[TBL] [Abstract][Full Text] [Related]
38. Surgical preferences in the management of recalcitrant endophthalmitis.
Fu R; Childs J; Nunery W; Timoney P
Orbit; 2018 Oct; 37(5):315-320. PubMed ID: 29300514
[TBL] [Abstract][Full Text] [Related]
39. Late exposure of the bioceramic orbital implant.
Wang JK; Lai PC; Liao SL
Am J Ophthalmol; 2009 Jan; 147(1):162-170.e1. PubMed ID: 18571617
[TBL] [Abstract][Full Text] [Related]
40. Evisceration with primary implant placement in patients with endophthalmitis.
Tawfik HA; Budin H
Ophthalmology; 2007 Jun; 114(6):1100-3. PubMed ID: 17258811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]